Q3-FY26 · Raju Panini
We're actively pursuing two three targets and we're hoping we'll able to close. Something large we want to close at least one in 2026 we want to close in this calendar year for sure.
Natco Pharma · tone and specificity signals across the available quarters.
Language signals
We're actively pursuing two three targets and we're hoping we'll able to close. Something large we want to close at least one in 2026 we want to close in this calendar year for sure.
My expectation is that they're going to be a lot of generics. Each guy you know we're launching our own brand plus also be giving to two other people. So again all the other guys also I think they're launching their own brand. It'll be like a crowded generic market.
Without M&A you will not get there. Organically, you'll get to a certain point but you need to do M&A for sure. And do I have such a number in mind? Of course, we have this number in mind. I'm totally aware of it.